{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T09:40:38Z","timestamp":1777369238782,"version":"3.51.4"},"reference-count":91,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2022,2,18]],"date-time":"2022-02-18T00:00:00Z","timestamp":1645142400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Pfizer (Italy)","award":["2020-7"],"award-info":[{"award-number":["2020-7"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Microorganisms"],"abstract":"<jats:p>Tick-borne encephalitis (TBE) is endemic in several European countries, and its incidence has recently increased. Various factors may explain this phenomenon: social factors (changes in human behavior, duration and type of leisure activities and increased tourism in European high-risk areas), ecological factors (e.g., effects of climate change on the tick population and reservoir animals), and technological factors (improved diagnostics, increased medical awareness). Furthermore, the real burden of TBE is not completely known, as the performance of surveillance systems is suboptimal and cases of disease are under-reported in several areas. Given the potentially severe clinical course of the disease, the absence of any antiviral therapy, and the impossibility of interrupting the transmission of the virus in nature, vaccination is the mainstay of prevention and control. TBE vaccines are effective (protective effect of approximately 95% after completion of the basic vaccination\u2014three doses) and well tolerated. However, their uptake in endemic areas is suboptimal. In the main endemic countries where vaccination is included in the national\/regional immunization program (with reimbursed vaccination programs), this decision was driven by a cost-effectiveness assessment (CEA), which is a helpful tool in the decision-making process. All CEA studies conducted have demonstrated the cost-effectiveness of TBE vaccination. Unfortunately, CEA is still lacking in many endemic countries, including Italy. In the future, it will be necessary to fill this gap in order to introduce an effective vaccination strategy in endemic areas. Finally, raising awareness of TBE, its consequences and the benefit of vaccination is critical in order to increase vaccination coverage and reduce the burden of the disease.<\/jats:p>","DOI":"10.3390\/microorganisms10020464","type":"journal-article","created":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T08:22:19Z","timestamp":1645431739000},"page":"464","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Vaccination against Tick-Borne Encephalitis (TBE) in Italy: Still a Long Way to Go"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2677-0551","authenticated-orcid":false,"given":"Donatella","family":"Panatto","sequence":"first","affiliation":[{"name":"Department of Health Sciences, University of Genoa, Via A. Pastore 1, 16132 Genoa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9608-8892","authenticated-orcid":false,"given":"Alexander","family":"Domnich","sequence":"additional","affiliation":[{"name":"Hygiene Unit, San Martino Policlinico Hospital, Largo R. Benzi 10, 16132 Genoa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9707-5214","authenticated-orcid":false,"given":"Daniela","family":"Amicizia","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University of Genoa, Via A. Pastore 1, 16132 Genoa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Reggio","sequence":"additional","affiliation":[{"name":"Vaccine Medical Department, Pfizer Srl., Via Valbondione, 113, 00188 Roma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaella","family":"Iantomasi","sequence":"additional","affiliation":[{"name":"Vaccine Medical Department, Pfizer Srl., Via Valbondione, 113, 00188 Roma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,2,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.4161\/hv.23802","article-title":"Epidemiology of Tick-Borne Encephalitis (TBE) in Europe and Its Prevention by Available Vaccines","volume":"9","author":"Amicizia","year":"2013","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.4161\/hv.29984","article-title":"Immunogenicity against Far Eastern and Siberian Subtypes of Tick-borne Encephalitis (TBE) Virus Elicited by the Currently Available Vaccines Based on the European Subtype: Systematic Review and Meta-Analysis","volume":"10","author":"Domnich","year":"2014","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0140-6736(08)60800-4","article-title":"Tick-Borne Encephalitis","volume":"371","author":"Lindquist","year":"2008","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/jmv.20224","article-title":"Characterization of Tick-Borne Encephalitis Virus from Estonia","volume":"74","author":"Golovljova","year":"2004","journal-title":"J. Med. Virol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/jmedent\/31.2.240","article-title":"Geographical Distribution, Host Associations, and Vector Roles of Ticks (Acari: Ixodidae, Argasidae) in Sweden","volume":"31","author":"Jaenson","year":"1994","journal-title":"J. Med. Entomol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/jmv.10497","article-title":"Characterisation of Human Tick-Borne Encephalitis Virus from Sweden","volume":"71","author":"Haglund","year":"2003","journal-title":"J. Med. Virol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/BF00145300","article-title":"Family Outbreak of Alimentary Tick-Borne Encephalitis in Slovakia Associated with a Natural Focus of Infection","volume":"12","author":"Kohl","year":"1996","journal-title":"Eur. J. Epidemiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1093\/brain\/122.11.2067","article-title":"The Clinical and Epidemiological Profile of Tick-Borne Encephalitis in Southern Germany 1994\u20131998: A Prospective Study of 656 Patients","volume":"122","author":"Kaiser","year":"1999","journal-title":"Brain"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1086\/342059","article-title":"Tick-Borne Encephalitis in an Area of High Endemicity in Lithuania: Disease Severity and Long-Term Prognosis","volume":"35","author":"Mickiene","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s004150050077","article-title":"Tick-Bone Encephalitis in Sweden in Relation to Aseptic Meningoencephalitis of Other Etiology: A Prospective Study of Clinical Course and Outcome","volume":"244","author":"Gunther","year":"1997","journal-title":"J. Neurol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.antiviral.2019.01.014","article-title":"Tick-Borne Encephalitis in Europe and Russia: Review of Pathogenesis, Clinical Features, Therapy, and Vaccines","volume":"164","author":"Ruzek","year":"2019","journal-title":"Antivir. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1159\/000503236","article-title":"Do We Know the True Burden of Tick-Borne Encephalitis? A Cross-Sectional Study","volume":"54","author":"Cocchio","year":"2020","journal-title":"Neuroepidemiology"},{"key":"ref_13","unstructured":"European Centre for Disease Prevention and Control (ECDC) (2021). Tick-Borne Encephalitis, ECDC. Available online: https:\/\/www.ecdc.europa.eu\/en\/publications-data\/tick-borne-encephalitis-annual-epidemiological-report-2019."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ttbdis.2010.10.007","article-title":"Tick-Borne Encephalitis 2010: Epidemiology, Risk Areas, and Virus Strains in Europe and Asia\u2014An Overview","volume":"2","author":"Suss","year":"2011","journal-title":"Ticks Tick Borne Dis."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Beaut\u00e9, J., Spiteri, G., Warns-Petit, E., and Zeller, H. (2018). Tick-Borne Encephalitis in Europe, 2012 to 2016. Eurosurveillance, 23.","DOI":"10.2807\/1560-7917.ES.2018.23.45.1800201"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Taba, P., Schmutzhard, E., Forsberg, P., Lutsar, I., Lj\u00f8stad, U., Mygland, \u00c5., Levchenko, I., Strle, F., and Steiner, I. (2017). EAN Consensus Review on Prevention, Diagnosis and Management of Tick-Borne Encephalitis. Eur. J. Neurol., 24.","DOI":"10.1111\/ene.13356"},{"key":"ref_17","first-page":"211","article-title":"Tick-Borne Encephalitis in the Czech Republic in 2019\u2013Report on the Epidemiological Situation in the Context of Previous Years","volume":"29","author":"Lenz","year":"2020","journal-title":"CEM Rep."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3201\/eid1901.120458","article-title":"Vaccination and Tick-Borne Encephalitis, Central Europe","volume":"19","author":"Heinz","year":"2013","journal-title":"Emerg. Infect. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"21077","DOI":"10.2807\/1560-7917.ES2015.20.13.21077","article-title":"Emergence of Tick-Borne Encephalitis in New Endemic Areas in Austria: 42 Years of Surveillance","volume":"20","author":"Heinz","year":"2015","journal-title":"Eurosurveillance"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Rubel, F., Walter, M., Vogelgesang, J.R., and Brugger, K. (2020). Tick-Borne Encephalitis (TBE) Cases Are Not Random: Explaining Trend, Low- and High-Frequency Oscillations Based on the Austrian TBE Time Series. BMC Infect. Dis., 20.","DOI":"10.1186\/s12879-020-05156-7"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1002\/jmv.23313","article-title":"Persistence of Immunity to Tick-Borne Encephalitis after Vaccination and Natural Infection","volume":"84","author":"Baldovin","year":"2012","journal-title":"J. Med. Virol."},{"key":"ref_22","first-page":"77","article-title":"Tick-Borne Encephalitis (TBE) in Italy: Report of the First Clinical Case","volume":"97","author":"Amaducci","year":"1976","journal-title":"Riv. Patol. Nerv. Ment."},{"key":"ref_23","unstructured":"Verani, P., Ciufolini, M.G., and Nicoletti, I. (1979, January 19\u201320). Circulation of TBE Virus in Italy: Seroepidemiological and Ecovirological Studies. Proceedings of the Abstract of the International Symposium on Tick-Borne Encephalitis, Baden\/Wien, Austria."},{"key":"ref_24","first-page":"294","article-title":"TBE Virus-Related Disease in the Belluno Area (North-East Italy): Preliminary Report of 15 Cases","volume":"2","author":"Caruso","year":"1996","journal-title":"G. Ital. Mal. Infett."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1046\/j.0269-283x.2001.00317.x","article-title":"Tick-Borne Encephalitis Virus in Northern Italy: Molecular Analysis, Relationships with Density and Seasonal Dynamics of Ixodes Ricinus","volume":"15","author":"Hudson","year":"2001","journal-title":"Med. Veter.-\u00c8ntomol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s10072-006-0612-0","article-title":"Neurological Manifestation of Tick-Borne Encephalitis in North-Eastern Italy","volume":"27","author":"Cruciatti","year":"2006","journal-title":"Neurol. Sci."},{"key":"ref_27","unstructured":"Dobler, G., Erber, W., Broeker, M., and Schmitt, H.-J. (2020). TBE Book, Global Health Press. [4th ed.]."},{"key":"ref_28","unstructured":"Ricc\u00f2, M. (2021). Epidemiology of Tick-Borne Encephalitis in North-Eastern Italy (2017\u20132020): International Insights from National Notification Reports. Acta Biomed., 92."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Rezza, G., Farchi, F., Pezzotti, P., Ruscio, M., Presti, A.L., Ciccozzi, M., Mondardini, V., Paternoster, C., Bassetti, M., and Merelli, M. (2015). Tick-borne Encephalitis in North-East Italy: A 14-Year Retrospective Study, January 2000 to December 2013. Eurosurveillance, 20.","DOI":"10.2807\/1560-7917.ES.2015.20.40.30034"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1080\/22221751.2020.1730246","article-title":"Tick-Borne Encephalitis Foci in Northeast Italy Revealed by Combined Virus Detection in Ticks, Serosurvey on Goats and Human Cases","volume":"9","author":"Alfano","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"ref_31","unstructured":"Istituto Superiore di Sanit\u00e0 (2021, November 05). Epicentro. Sistema Nazionale di Sorveglianza delle Arbovirosi: I Bollettini Periodici Annual Report. Available online: https:\/\/www.epicentro.iss.it\/arbovirosi\/bollettini."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Cafiso, A., Olivieri, E., Floriano, A., Chiappa, G., Serra, V., Sassera, D., and Bazzocchi, C. (2021). Investigation of Tick-Borne Pathogens in Ixodes Ricinus in a Peri-Urban Park in Lombardy (Italy) Reveals the Presence of Emerging Pathogens. Pathogens, 10.","DOI":"10.3390\/pathogens10060732"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1586\/14760584.2015.985661","article-title":"Review of Tick-Borne Encephalitis and Vaccines: Clinical and Economical Aspects","volume":"14","author":"Postma","year":"2015","journal-title":"Expert Rev. Vaccines"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Kohlmaier, B., Schweintzger, N.A., Sagmeister, M.G., \u0160vendov\u00e1, V., Kohlf\u00fcrst, D.S., Sonnleitner, A., Leitner, M., Berghold, A., Schmiedberger, E., and Fazekas, F. (2021). Clinical Characteristics of Patients with Tick-Borne Encephalitis (TBE): A European Multicentre Study from 2010 to 2017. Microorganisms, 9.","DOI":"10.3390\/microorganisms9071420"},{"key":"ref_35","first-page":"115","article-title":"The Clinical Features of Tick-Borne Encephalitis in Slovenia. A Study of 492 Cases in 1994","volume":"12","author":"Tomazic","year":"1996","journal-title":"Antibiot. Monit."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"6301","DOI":"10.1016\/j.vaccine.2012.07.083","article-title":"Cost-Effectiveness of Tick-Borne Encephalitis Vaccination in Slovenian Adults","volume":"30","year":"2012","journal-title":"Vaccine"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"\u0160mit, R., and Postma, M.J. (2014). Disability-Adjusted Life Years (DALYs) as a Composite Measure to Express the Burden of Tick-Borne Encephalitis (TBE) in Slovenia. Value Health, 17.","DOI":"10.1016\/j.jval.2014.08.2458"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"\u0160mit, R., and Postma, M.J. (2015). The Burden of Tick-Borne Encephalitis in Disability-Adjusted Life Years (DALYs) for Slovenia. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0144988"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1017\/S0950268818002005","article-title":"Sequelae of Tick-Borne Encephalitis in Retrospective Analysis of 1072 Patients","volume":"146","author":"Czupryna","year":"2018","journal-title":"Epidemiol. Infect."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.idc.2008.03.013","article-title":"Tick-Borne Encephalitis","volume":"22","author":"Kaiser","year":"2008","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"ref_41","unstructured":"Demicheli, V., Graves, P., Pratt, M., and Jefferson, T. (2000). Vaccines for Preventing Tick-Borne Encephalitis. Cochrane Database Syst. Rev., 2."},{"key":"ref_42","unstructured":"Ministero della Salute (2021, May 20). Piano Nazionale Prevenzione Vaccinale 2017\u20132019, Available online: http:\/\/www.salute.gov.it\/portale\/documentazione\/p6_2_2_1.jsp?id=2571.b."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ijmm.2006.01.019","article-title":"FSME-IMMUN 05 mL Using a Rapid Immunization Schedule","volume":"296","author":"Poellabauer","year":"2006","journal-title":"Int. J. Med. Microbiol."},{"key":"ref_44","first-page":"S130","article-title":"Long-Term Immunity after Vaccination against Tick-Borne Encephalitis with Encepur using the Rapid Vaccination Schedule","volume":"293","author":"Beran","year":"2004","journal-title":"Int. J. Med. Microbiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0264-410X(03)00563-2","article-title":"Randomized, Phase II Dose-Finding Studies of a Modified Tick-Borne Encephalitis Vaccine: Evaluation of Safety and Immunogenicity","volume":"22","author":"Ehrlich","year":"2003","journal-title":"Vaccine"},{"key":"ref_46","first-page":"126","article-title":"Randomized, Phase II, Multicenter Dose-Finding Studies of a Modified Tick-Borne Encephalitis Vaccine in Children: Evaluation of Safety and Immunogenicity of Two Vaccinations with FSME-Immun\u00ae\u201cNew\u201d","volume":"293","author":"Ehrlich","year":"2004","journal-title":"Int. J. Med. Microbiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"5256","DOI":"10.1016\/j.vaccine.2006.03.061","article-title":"Safety and Immunogenicity of the Modified Adult Tick-Borne Encephalitis Vaccine FSME-IMMUN: Results of Two Large Phase 3 Clinical Studies","volume":"24","author":"Konior","year":"2006","journal-title":"Vaccine"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"7307","DOI":"10.1016\/j.vaccine.2011.07.089","article-title":"Prevention of Tick-Borne Encephalitis by FSME-IMMUN Vaccines: Review of a Clinical Development Programme","volume":"29","author":"Poellabauer","year":"2011","journal-title":"Vaccine"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1016\/j.vaccine.2010.04.075","article-title":"Clinical Evaluation to Determine the Appropriate Paediatric Formulation of a Tick-Borne Encephalitis Vaccine","volume":"28","author":"Fritsch","year":"2010","journal-title":"Vaccine"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"4680","DOI":"10.1016\/j.vaccine.2010.04.047","article-title":"Comparison of Immunogenicity and Safety between Two Paediatric TBE Vaccines","volume":"28","author":"Pavlova","year":"2010","journal-title":"Vaccine"},{"key":"ref_51","unstructured":"(2022, January 10). FSME-IMMUN\u00ae 0.5 mL. Summary of Product Characteristics (European). Last Updated: August 2021. Available online: https:\/\/mri.cts-mrp.eu\/human\/downloads\/AT_H_0126_002_FinalSPC.pdf."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Pugh, S.J., Mo\u00efsi, J.C., Kundi, M., Santonja, I., Erber, W., Angulo, F.J., and Jodar, L. (2022). Effectiveness of Two Doses of Tick-Borne Encephalitis (TBE) Vaccine. J. Travel Med.","DOI":"10.1093\/jtm\/taab193"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.vaccine.2021.12.028","article-title":"Effectiveness of TBE vaccination in southern Germany and Latvia","volume":"40","author":"Erber","year":"2021","journal-title":"Vaccine"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"551","DOI":"10.4161\/hv.5.8.8571","article-title":"Seropersistence of Tick-Borne Encephalitis Antibodies, Safety and Booster Response to FSME-IMMUN 0.5 mL in Adults Aged 18\u201367 Years","volume":"5","author":"Poellabauer","year":"2009","journal-title":"Hum. Vaccines"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"736","DOI":"10.4161\/hv.20058","article-title":"Antibody Persistence after Two Vaccinations with Either FSME-IMMUN\u00ae Junior or ENCEPUR\u00ae Children Followed by Third Vaccination with FSME-IMMUN\u00ae Junior","volume":"8","author":"Prymula","year":"2012","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/j.vaccine.2008.10.003","article-title":"Antibody Response Following Administration of Two Paediatric Tick-Borne Encephalitis Vaccines Using Two Different Vaccination Schedules","volume":"27","author":"Wittermann","year":"2009","journal-title":"Vaccine"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1016\/S0264-410X(02)00813-7","article-title":"TBE Vaccination and the Austrian Experience","volume":"21","author":"Kunz","year":"2003","journal-title":"Vaccine"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"7559","DOI":"10.1016\/j.vaccine.2007.08.024","article-title":"Field Effectiveness of Vaccination against Tick-Borne Encephalitis","volume":"25","author":"Heinz","year":"2007","journal-title":"Vaccine"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Schmidt, A.J., Altpeter, E., Graf, S., and Steffen, R. (2021). Tick-Borne Encephalitis (TBE) in Switzerland: Does the Prolongation of Vaccine Booster Intervals Result in an Increased Risk of Breakthroughs?. J. Travel Med.","DOI":"10.1093\/jtm\/taab158"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1090.e7","DOI":"10.1016\/j.cmi.2019.12.001","article-title":"Tick-Borne Encephalitis Virus Vaccination Breakthrough Infections in Germany: A Retrospective Analysis from 2001 to 2018","volume":"26","author":"Dobler","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Schmitt, H.J., Dobler, G., Zavadska, D., Freimane, Z., Fousteris, D., Erber, W., Jodar, L., and Palmborg, A. (2021). TBE Vaccination Breakthrough Cases-Does Age Matter?. Vaccines, 9.","DOI":"10.3390\/vaccines9080932"},{"key":"ref_62","unstructured":"Wanke, K.H.L., Mekker, A., Steffen, R., Stiasny, K., Heinz, F.X., Unger, B., and Karrer, U. (April, January 31). Immunogenicity and Safety of Tick-Borne Encephalitis Vaccination in Healthy Elderly Individuals. Proceedings of the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), London, UK."},{"key":"ref_63","unstructured":"World Health Organization (2011). Vaccines against Tick-Borne Encephalitis: WHO Position Paper. Wkly. Epidemiol. Rec., 86, 241\u2013256."},{"key":"ref_64","first-page":"375","article-title":"Immunogenicity of a Booster Vaccination against Tick-Borne Encephalitis","volume":"85","author":"Beskovnik","year":"2016","journal-title":"Zdrav. Vestn."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1016\/j.vaccine.2017.03.059","article-title":"Seropersistence of TBE Virus Antibodies 10 Years after First Booster Vaccination and Response to a Second Booster Vaccination with FSME-IMMUN 0.5 mL in Adults","volume":"35","author":"Konior","year":"2017","journal-title":"Vaccine"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1016\/j.vaccine.2019.03.032","article-title":"Seropersistence and Booster Response Following Vaccination with FSME-IMMUN in Children, Adolescents, and Young Adults","volume":"37","author":"Poellabauer","year":"2019","journal-title":"Vaccine"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.1016\/j.vaccine.2017.12.081","article-title":"Second Five-Year Follow-Up after a Booster Vaccination against Tick-Borne Encephalitis following Different Primary Vaccination Schedules Demonstrates at Least 10 Years Antibody Persistence","volume":"37","author":"Beran","year":"2019","journal-title":"Vaccine"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"A347","DOI":"10.1016\/j.jval.2013.08.150","article-title":"Evaluating Economic Burden of Tick-Borne Encephalitis. Evidence from Russia","volume":"16","author":"Avxentev","year":"2013","journal-title":"Value Heath"},{"key":"ref_69","first-page":"551","article-title":"Health Economics of Early Summer Meningoencephalitis in Austria. Effects of a Vaccination Campaign 1981 to 1990","volume":"143","author":"Schwarz","year":"1993","journal-title":"Wien Med. Wochenschr."},{"key":"ref_70","first-page":"249","article-title":"Is Reimbursed Vaccination against Tick-Borne Encephalitis a Meaningful Investment from a Medical as Well as from an Economic Point of View?","volume":"16","author":"Decker","year":"2020","journal-title":"Farmakoterapie"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1586\/14760584.2016.1111142","article-title":"Vaccines for Tick-Borne Diseases and Cost-Effectiveness of Vaccination: A Public Health Challenge to Reduce the Diseases\u2019 Burden","volume":"15","author":"Postma","year":"2016","journal-title":"Expert Rev. Vaccines"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"7659","DOI":"10.1016\/j.vaccine.2018.10.086","article-title":"Estimating Costs and Health Outcomes of Publicly Funded Tick-Born Encephalitis Vaccination: A Cost-Effectiveness Analysis","volume":"36","author":"Shedrawy","year":"2018","journal-title":"Vaccine"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"6137","DOI":"10.1016\/j.vaccine.2021.08.074","article-title":"Vaccination Programs for Pregnant Women in Europe, 2021","volume":"39","author":"Maltezou","year":"2021","journal-title":"Vaccine"},{"key":"ref_74","unstructured":"Giunta Regionale del Veneto [Internet] (2019, September 05). Bollettino Ufficiale della Regione del Veneto. Available online: https:\/\/bur.regione.veneto.it\/BurvServices\/pubblica\/DettaglioDgr.aspx?id=394640."},{"key":"ref_75","unstructured":"Giunta Regionale Regione Autonoma Friuli Venezia Giulia (2021, December 10). Delibera n. 1311 del 25\/07\/2012. Available online: https:\/\/www.epicentro.iss.it\/vaccini\/pdf\/Normative\/FriuliVeneziaGiulia_Settembre%202012\/Estensione%20%20DGR%20n%C2%B0%201311%20del%2025.7.2012.pdf."},{"key":"ref_76","unstructured":"Giunta Provinciale Provincia Autonoma di Trento (2021, December 10). Delibera n. 1021 del 23\/06\/2017. Available online: https:\/\/www.vaccinarsintrentino.org\/assets\/uploads\/files\/7\/del-gp-1021\u20132017-recepim-pnv.pdf."},{"key":"ref_77","unstructured":"Giunta Provinciale Provincia Autonoma di Bolzano (2021, December 10). Delibera n. 1497 del 29\/12\/2017. Available online: http:\/\/lexbrowser.provinz.bz.it\/doc\/it\/210701\/delibera_28_dicembre_2017_n_1497.aspx?view=1."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Ricc\u00f2, M., Gualerzi, G., Ranzieri, S., Ferraro, P., and Bragazzi, N.L. (2020). Knowledge, Attitudes, Practices (KAP) of Italian Occupational Physicians towards Tick Borne Encephalitis. Trop. Med. Infect. Dis., 5.","DOI":"10.3390\/tropicalmed5030117"},{"key":"ref_79","unstructured":"Regione Autonoma Friuli Venezia Giulia (2021, December 10). Attivit\u00e0 di Prevenzione Sanitaria Contro l\u2019Encefalite Trasmessa da Zecca. Copertura Vaccinale al 20\/05\/2016. Available online: http:\/\/www.aas3.sanita.fvg.it\/opencms\/export\/sites\/ass3\/it\/_organigramma\/5_dip_prevenzione\/4_med_comunita\/documenti\/attivita-di-prevenzione-sanitaria-contro-la-tbe.pdf."},{"key":"ref_80","first-page":"E497","article-title":"Drive-Through Vaccinations Prove Successful in Immunizing Mountain Communities against Tick-Borne Encephalitis during the COVID-19 Pandemic","volume":"61","author":"Schiavon","year":"2021","journal-title":"J. Prev. Med. Hyg."},{"key":"ref_81","first-page":"307","article-title":"Risk and Prevention of Tick-Borne Encephalitis in Travellers","volume":"11","year":"2004","journal-title":"J. Travel. Med."},{"key":"ref_82","unstructured":"Steffen, R. (2016). Epidemiology of Tick-Borne Encephalitis (TBE) in International Travellers to Western\/Central Europe and Conclusions on Vaccination Recommendations. J. Travel Med., 23."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1093\/jtm\/tay063","article-title":"Perceptions of Tick-Borne Encephalitis Risk: A Survey of Travellers and Travel Clinics from Canada, Germany, Sweden and the UK","volume":"26","author":"Marano","year":"2019","journal-title":"J. Travel Med."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1093\/jtm\/tay069","article-title":"Multinational Survey Shows Low Awareness of Tick-Borne Encephalitis and Rabies among Travellers to Endemic Regions","volume":"26","author":"Marano","year":"2019","journal-title":"J. Travel Med."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ttbdis.2018.08.004","article-title":"Report of the 20th Annual Meeting of the International Scientific Working Group on Tick-Borne Encepha-litis (ISW-TBE): ISW-TBE: 20 Years of Commitment and Still Challenges Ahead","volume":"10","author":"Kunze","year":"2019","journal-title":"Ticks Tick Borne Dis."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"362","DOI":"10.4161\/hv.22766","article-title":"Recommendations for Tick-Borne Encepha-Litis Vaccination from the Central European Vaccination Awareness Group (CEVAG)","volume":"9","author":"Zavadska","year":"2013","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_87","unstructured":"European Centre for Disease Prevention and Control (ECDC) (2021, May 15). Key Messages about Tick-Borne Encephalitis and Tick-Borne Diseases. Available online: https:\/\/www.ecdc.europa.eu\/en\/tick-borne-encephalitis\/facts\/key-messages."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"76","DOI":"10.32394\/pe.75.08","article-title":"Epidemiology of Tick-Borne Encephalitis in Poland (2010\u20132019) and the Impact of the COVID-19 Pandemic on the Notified Incidence of the Disease","volume":"75","author":"Sulik","year":"2021","journal-title":"Przegl Epidemiol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s10072-018-3274-9","article-title":"Aseptic Central Nervous System Infections in Adults: What Predictor for Unknown Etiological Diagnosis?","volume":"39","author":"Monticelli","year":"2018","journal-title":"Neurol. Sci."},{"key":"ref_90","unstructured":"Ministero della Salute (2019, September 05). Piano Nazionale di Sorveglianza e Risposta all\u2019Encefalite Virale da Zecche (2017), Available online: http:\/\/www.salute.gov.it\/porta-le\/news\/p3_2_1_1_1.jsp?lingua=italiano&menu=notizie&p=dalministero&id=3032."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.ttbdis.2018.02.007","article-title":"Self-Reported Tick-Borne Encephalitis (TBE) Vaccination Coverage in Europe: Results from a Cross-Sectional Study","volume":"9","author":"Erber","year":"2018","journal-title":"Ticks Tick Borne Dis."}],"container-title":["Microorganisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-2607\/10\/2\/464\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:22:18Z","timestamp":1760134938000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-2607\/10\/2\/464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,18]]},"references-count":91,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["microorganisms10020464"],"URL":"https:\/\/doi.org\/10.3390\/microorganisms10020464","relation":{},"ISSN":["2076-2607"],"issn-type":[{"value":"2076-2607","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,18]]}}}